Ambrosol syrup, 120 ml, couth and sore throats

Ambrosol Teva is a medicine in the form of syrup intended for use in adults and children over 2 years of age. The active substance of the preparation - ambroxol hydrochloride has expectorant and mucolytic properties. Diluting the mucus reduces its viscosity, while increasing the amount in the respiratory tract, which accelerates the transport of secretions, facilitates expectoration and relieves cough. The drug is indicated for use in acute and chronic respiratory diseases that result in difficult expectoration of viscous bronchial secretions, including:

• acute and chronic bronchitis,
• bronchial asthma,
• cystic fibrosis,
• emphysema,
• bronchiectasis.

Acute and chronic respiratory diseases with difficult expectoration of viscous bronchial secretions.

5 ml of Ambrosol syrup 30 mg/ 5 ml (1 measuring spoon) contains:

• active substance: 30 mg of ambroxol hydrochloride,
• excipients: liquid sorbitol 70% (E420), glycerol (E422), propylene glycol (E1520), methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), raspberry flavor, purified water.

Expectorant and mucolytic.

• Adults and children over 12 years of age:
  • Initially, for 2-3 days, you should use 5 ml of syrup, i.e. 1 measuring spoon (30 mg of ambroxol hydrochloride) 3 times a day.
  • Then the dose should be reduced to 5 ml of syrup twice a day.
• Children aged 6 to 12:
  • 2.5 ml of syrup, i.e. 1 measuring spoon (15 mg of ambroxol hydrochloride) 2-3 times a day;
• Children aged 2 to 6 years:
  • 1.25 ml of syrup, i.e. 1/4 measuring spoon (7.5 mg of ambroxol hydrochloride) 3 times a day;
• Children aged 1 to 2 years:
  • 1.25 ml of syrup, i.e. 1/4 measuring spoon (7.5 mg of ambroxol hydrochloride) 2 times a day.
• Do not use in children without consulting a doctor.
• If treatment lasts longer than 7-14 days, the dose should be reduced.
• The medicine should not be administered immediately before bedtime.

• Allergy (hypersensitivity) to the ingredients of the preparation; bronchospasm.
• Pregnant and breastfeeding women should consult a doctor before using the drug.
• If you have been told by your doctor that you have an intolerance to some sugars, consult your doctor before taking this medicinal product.

• Store out of the sight and reach of children, at a temperature below 25°C.
• Protect from light.
• After first opening, use within 28 days.

Ambrosol Teva, like all medicines, can cause side effects, although not everyone gets them.

Common side effects (may affect up to 1 in 10 people):

• taste disturbances (e.g. change in taste), nausea, decreased sensation (hypoaesthesia) in the mouth and throat.

Uncommon side effects (may affect up to 1 in 100 people):

• vomiting, diarrhea, abdominal pain, indigestion, dry mouth.

Rare side effects (may affect up to 1 in 1,000 people):

• hypersensitivity reactions,
• rash, hives,
• heartburn.

Side effects with unknown frequency (cannot be estimated from available data):

• anaphylactic reactions, including anaphylactic shock, angioedema and pruritus,
• serious skin side effects (including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis and acute generalized pustulosis),
• dry throat.

• Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
• Ambroxol should not be administered concomitantly with antitussive medications, including codeine, or mucus suppressants.
• Ambroxol increases the penetration of some antibiotics, including amoxicillin, cefuroxime, erythromycin, doxycycline into the lung parenchyma.

• You should discuss the use of Ambrosol Teva with your doctor, especially if:
  • if the patient suffers from a stomach or duodenal ulcer (the drug has an adverse effect on the gastric mucosa),
  • if you have liver or kidney problems,
  • when the patient has a weakened cough reflex or impaired ciliary clearance of the bronchi due to the possibility of secretions retaining in the respiratory tract.
• Liquefaction of large amounts of secretion in immobilized and seriously ill patients, as well as in small children, must be combined with its suction (in such a case, drugs that inhibit the cough reflex should not be administered as this may result in the accumulation of secretions in the respiratory tract).
• Bronchial secretions should always be expectorated thoroughly.
• In patients with bronchial asthma, ambroxol may initially worsen cough
• The medicine contains:
  • methyl parahydroxybenzoate and propyl parahydroxybenzoate, which may cause allergic reactions (possible delayed reactions),
  • 150 mg of propylene glycol in 5 ml of syrup, which corresponds to 3.6 g of propylene glycol in 120 ml of syrup and 6 g of propylene glycol in 200 ml of syrup,
  • 2.25 g of sorbitol in 5 ml (sorbitol is a source of fructose).

Pregnancy and breastfeeding

• If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
• The active substance of the drug penetrates the placental barrier: it is not recommended to use the drug during pregnancy, especially in the first three months of pregnancy.
• Ambroxol hydrochloride passes into breast milk: it is not recommended to use the drug during breastfeeding.